Please ensure Javascript is enabled for purposes of website accessibility

3 Dividend Stocks to Buy Hand Over Fist If the Market Crashes

By Keith Speights – Jul 25, 2021 at 5:55AM

Key Points

  • Buying certain dividend stocks during a major market downturn can enable investors to obtain very attractive dividend yields.
  • These three stocks already offer high yields that would move even higher during a market crash.
  • The underlying businesses behind the stocks are also solid.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

You'll be able to lock in fantastic dividend yields if you do.

I am absolutely convinced that the stock market is going to crash. However, I don't have the remotest idea when it will happen. It could be in 2021 or it could be several years from now.

There's also something else that I'm convinced about: Buying certain dividend stocks when the market crashes is a smart idea. You can lock in fantastic yields when you invest in the right dividend stocks that are trading at low prices. 

What are the best stocks to scoop up during a major market meltdown? The list includes quite a few great picks. Here are three dividend stocks that I especially think are ones to buy hand over fist if the market crashes.

Hand holding a pin next to a bubble with a dollar sign inside it.

Image source: Getty Images.

AbbVie

AbbVie (ABBV 0.20%) already offers a juicy dividend yield of more than 4.5%. And you can count on the company's dividend continuing to flow and grow. AbbVie is only one dividend hike away from joining the group of stocks known as Dividend Kings -- S&P 500 members with at least 50 consecutive years of dividend increases.

What would happen with AbbVie during a stock market crash? Shares of the big drugmaker would likely fall as they did during the coronavirus-fueled sell-off last year. That would push its dividend yield even higher. However, AbbVie stock would probably be among the first to rebound because of the strength of its underlying business.

To be sure, AbbVie faces some uncertainties. The company's top-selling drug, Humira, faces biosimilar competition in the U.S. beginning in 2023 with sales almost certain to fall. The U.S. Food and Drug Administration (FDA) has held up approval decisions for JAK inhibitor Rinvoq in three indications because of safety concerns raised by Pfizer's post-approval clinical study of Xeljanz, which is also a JAK inhibitor. 

But Rinvoq has already received FDA approval in treating rheumatoid arthritis. AbbVie remains confident that it will pick up additional approvals. The company also projects a quick return to overall sales growth after a temporary dip in 2023 due to an anticipated sales decline for Humira. I don't think AbbVie's dividend will be in any jeopardy -- and in the event of a market crash, it would be especially attractive.

Easterly Government Properties

There are a handful of dividend stocks that I'd buy right now without even a moment's hesitationEasterly Government Properties (DEA -1.37%) ranks high on that list. 

It's not just because of Easterly's dividend yield of 4.8% (although it's hard not to really like that yield). What I especially find compelling about this stock is its underlying business model that makes that dividend one of the safest you'll find on the market.

Easterly's name pretty much tells the story. The company owns and leases out government properties. As of March 31, 2021, Easterly's portfolio included 82 properties, of which 80 were leased to U.S. government agencies. Since then, the company has acquired a building in Kansas City, Missouri, that's leased to the National Weather Service. 

I can't think of a more secure tenant than the U.S. government. If the day ever comes where Uncle Sam can't make its lease payments, we'll have a lot more to worry about than just a stock market crash.

Enterprise Products Partners

Enterprise Products Partners (EPD -0.89%) was one great dividend stock that I personally bought during the stock market plunge last year. By doing so, I locked in a dividend yield of nearly 12%.

The midstream energy stock has soared since the big sell-off of 2020. As a result, its dividend yield has also fallen quite a bit but still stands at a mouth-watering 7.6%.

But could Enterprise Products Partners be in trouble over the long run as the use of fossil fuels drops? Maybe. I'm not too worried, though. The company arguably has a killer advantage with its heavy focus on lower-emission natural gas, natural gas liquids, and lower sulfur crude oil. 

Also, Enterprise Products Partners is looking at opportunities to expand into carbon capture, hydrogen, recycling, and renewable fuels. These won't come anywhere close to supplanting the company's core business. However, Enterprise is committed to an "all-of-the-above" approach that I suspect will pay off for investors for a long time to come.

Keith Speights owns shares of AbbVie, Enterprise Products Partners, and Pfizer. The Motley Fool recommends Easterly Government Properties and Enterprise Products Partners. The Motley Fool has a disclosure policy.

Stocks Mentioned

Enterprise Products Partners Stock Quote
Enterprise Products Partners
EPD
$24.63 (-0.89%) $0.22
Pfizer Stock Quote
Pfizer
PFE
$50.47 (-0.86%) $0.44
AbbVie Stock Quote
AbbVie
ABBV
$163.98 (0.20%) $0.32
Easterly Government Properties Stock Quote
Easterly Government Properties
DEA
$15.52 (-1.37%) $0.21

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.